Arabic Arabic English English French French German German
dark

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – Jan 11, 2022

Mirum Pharmaceuticals, Inc. announced that on January 10, 2022, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 51,700 shares of common stock and 7,150 restricted stock units to five new employees under Mirum’s 2020 Inducement Plan. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Avinger Announces 510(k) Clearance for Lightbox 3 Next-Generation Imaging Console

Next Post

Why Marijuana is Being Used for Health Benefits

Related Posts
Total
0
Share